ARQT · Arcutis Biotherapeutics, Inc. · Documents
$31.75
-0.12 (-0.38%)
At close · Oct 22
Return incl. dividend (before tax)
Market Cap
$3.99B
Shares
125.69M
Volume · Oct 21
1.69M
Avg daily vol (3M)
2.4M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2021-08-05 | — | |
| 10-Q | — | 2021-08-05 | 2021-06-30 | |
| 8-K | — | 2021-06-14 | 2021-06-08 | |
| 10-Q | — | 2021-05-06 | 2021-03-31 | |
| 8-K | — | 2021-05-04 | — | |
| DEFA14A | — | 2021-04-27 | — | |
| DEF 14A | — | 2021-04-27 | 2021-06-09 | |
| 8-K | — | 2021-03-26 | 2021-03-22 | |
| 8-K | — | 2021-02-16 | — | |
| 10-K | — | 2021-02-16 | 2020-12-31 | |
| 8-K | — | 2021-02-05 | 2021-02-01 | |
| S-3ASR | — | 2021-02-01 | — | |
| 8-K | — | 2021-02-01 | — | |
| 8-K | — | 2021-01-15 | 2020-11-24 | |
| 8-K | — | 2020-11-23 | — | |
| 10-Q | — | 2020-11-05 | 2020-09-30 | |
| 8-K | — | 2020-11-05 | — | |
| 8-K | — | 2020-11-04 | 2020-10-29 | |
| 8-K | — | 2020-10-06 | 2020-10-01 | |
| 8-K | — | 2020-09-29 | — | |
| S-1 | — | 2020-09-29 | — | |
| 8-K | — | 2020-09-18 | 2020-09-16 | |
| 8-K | — | 2020-09-09 | 2020-09-08 | |
| 8-K | — | 2020-08-11 | — | |
| 10-Q | — | 2020-08-11 | 2020-06-30 | |
| 8-K | — | 2020-07-31 | — | |
| 8-K | — | 2020-07-29 | 2020-07-23 | |
| 8-K | — | 2020-05-13 | 2020-05-12 | |
| 10-Q | — | 2020-05-12 | 2020-03-31 | |
| 8-K | — | 2020-04-29 | 2020-04-22 | |
| 8-K | — | 2020-04-27 | 2020-04-23 | |
| 10-K | — | 2020-03-19 | 2019-12-31 | |
| S-1/A | — | 2020-01-21 | — | |
| S-1 | — | 2020-01-06 | — |
Showing 101–134 of 134 filings
Key facts
CIK
1787306
CUSIP
03969K108
13F (30d)
33 filings
33 filers
Visit website
Investor relations